Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02109731 · ClinicalTrials.gov registry record · NA

Upper Airway Physical Therapy for the Treatment of Obstructive Sleep Apnea

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT02109731: Completed NA study, sponsored by University of Rochester.

NCT02109731 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02109731, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effectiveness and feasibility of upper airway muscle physical therapy utilizing negative airway pressure (NAP) breathing training in patients with Obstructive Sleep Apnea Syndrome (OSAS) in reducing both signs (apnea hypopnea index) and symptoms (i.e., daytime sleepiness).The key to the proposed therapy is the use of Negative Air Pressure when awake so that the increased reflex phasic drive to the muscles will result in muscle conditioning. Interestingly, other studies have indicated that upper airway muscle training may be useful in treating OSAS, but these studies used techniques that were not scientifically designed{Puhan, 2006 8195 /id} or used a technique (electrical stimulation) that was not well tolerated.{Lequeux, 2005 7514 /id}

Primary Outcome

The pre-study AHI (before the NAP treatment was applied) was measured and quantified and compared to the post study AHI (after three months of NAP treatment) and the difference between pre and post therapy is reported. The AHI is an hourly rate of breathing disturbance (apneas and hypopneas per hour) that is calculated while subjects are evaluated during an overnight sleep study, with polysomnography applied (PSG). For example, while a subject is spending the night in the PSG laboratory sleeping

Interventions

  • OTHER Negative airway pressure delivery

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2009-01
Est. Completion 2012-01
Phase NA
University of Rochester

636 total trials

What the finished NCT02109731 record still lists

NCT02109731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Negative airway pressure delivery is the first listed.

NCT02109731 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02109731 about?

NCT02109731 is a clinical study titled "Upper Airway Physical Therapy for the Treatment of Obstructive Sleep Apnea". The purpose of this study is to determine the effectiveness and feasibility of upper airway muscle physical therapy utilizing negative airway pressure (NAP) breathing training in patients with Obstructive Sleep Apnea Syndrome (OSAS) in reducing both signs (apnea hypopnea index) and symptoms (i.e., d...

What is the current status of trial NCT02109731?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2009-01. Estimated completion is 2012-01.

What interventions are being tested in trial NCT02109731?

The interventions under investigation include: Negative airway pressure delivery (OTHER).

Who is sponsoring clinical trial NCT02109731?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02109731's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02109731, the US trial registry maintained by the National Library of Medicine. NCT02109731 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.